PTC Therapeutics (PTCT) Target Lifted to $81 at Wedbush

March 2, 2015 12:52 PM

Wedbush analyst Heather Behanna reiterated an Outperform rating and boosted her price target on PTC Therapeutics (NASDAQ: PTCT) to $81.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found